Hutch News

Hutch News

Stories tagged 'Transplant and Immunotherapy'

‘Article of the Year’ nod to demo of machine learning for personalized medicine

Computer-generated algorithms could guide prevention, treatment of transplant complication, researchers showed

April 17, 2018 | By Susan Keown / Fred Hutch News Service

In its April issue, the American Journal of Epidemiology recognized a paper by Fred Hutchinson Cancer Research Center faculty member Dr. Elizabeth Krakow as one of its 10 best articles published in 2017.

View story >


Immunotherapy strategy for ovarian cancer aims to rewire a ‘kill switch’ to ramp-up signal

T cells bearing a new engineered protein boost immunotherapy’s effectiveness in laboratory models of AML, ovarian, pancreatic cancers

April 16, 2018 | By Rachel Tompa / Fred Hutch News Service

In an effort to improve the efficacy of immunotherapy for solid tumors, Fred Hutch researchers have engineered a new type of protein that can rewire a 'kill switch' to stimulate T cells' activity instead.

View story >


How does leukemia escape from immunotherapy?

New tech enables deep dive into mysterious results, sets stage for future improvements

April 16, 2018 | By Susan Keown / Fred Hutch News Service

“We don’t stop asking what we can do better”: Fred Hutch researchers delve into failures to learn how to improve an experimental cancer immunotherapy.

View story >


An opening night for heroes

Cancer survivor Rose Ibarra to be honored by Fred Hutch and Mariners at Safeco Field

March 29, 2018 | By Sabin Russell / Fred Hutch News Service

A two-time survivor of acute lymphoblastic leukemia, Rose Ibarra of West Seattle is the first of nine “Hutch Heroes” to be honored by the Mariners and Fred Hutch during Thursday home games this season.

View story >


Learning more from T-cell therapy trials

Fred Hutch Immunotherapy Integrated Research Center awards grants to Drs. Brian Till, Cameron Turtle

March 28, 2018 | By Susan Keown / Fred Hutch News Service

Two Hutch teams have received new funding for in-depth study of the results emerging from ongoing trials of genetically engineered T-cell therapies.

View story >


Society for Immunotherapy of Cancer to honor Dr. Phil Greenberg

Immunology research leader named 2018 recipient of Richard V. Smalley, M.D., Memorial Award and Lectureship

March 23, 2018

On March 22, the Society for Immunotherapy of Cancer announced Fred Hutch's Dr. Philip Greenberg as the 2018 recipient of the Richard V. Smalley, M.D., Memorial Award and Lectureship, the society’s highest honor.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.